Advanced company searchLink opens in new window

HEXIGONE INHIBITORS LIMITED

Company number 10226176

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
13 Dec 2024 AA Total exemption full accounts made up to 30 June 2024
29 Nov 2024 CS01 Confirmation statement made on 2 November 2024 with updates
29 May 2024 TM01 Termination of appointment of Philip Anthony Buck as a director on 22 February 2024
28 May 2024 TM01 Termination of appointment of Neil Patrick Macdougall as a director on 15 May 2024
28 May 2024 AP01 Appointment of Mr Michael James Owens as a director on 22 February 2024
04 Apr 2024 MA Memorandum and Articles of Association
03 Apr 2024 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
27 Mar 2024 PSC08 Notification of a person with significant control statement
27 Mar 2024 PSC07 Cessation of Patrick Charles Dodds as a person with significant control on 22 February 2024
27 Mar 2024 SH01 Statement of capital following an allotment of shares on 22 February 2024
  • GBP 4,926.07
27 Mar 2024 SH01 Statement of capital following an allotment of shares on 22 February 2024
  • GBP 4,926.07
12 Feb 2024 RP04CS01 Second filing of Confirmation Statement dated 2 November 2023
07 Dec 2023 RP04CS01 Second filing of Confirmation Statement dated 2 November 2023
27 Nov 2023 RP04CS01 Second filing of Confirmation Statement dated 2 November 2023
02 Nov 2023 CS01 02/11/23 Statement of Capital gbp 3547.6
  • ANNOTATION Clarification a second filed CS01 (Statement of Capital and Shareholder Information) was registered on 27/11/2023 and again 07/12/2023. and again on 12/02/24
02 Nov 2023 PSC04 Change of details for Dr Patrick Charles Dodds as a person with significant control on 19 May 2023
02 Nov 2023 SH01 Statement of capital following an allotment of shares on 13 October 2023
  • GBP 3,547.6
11 Oct 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
01 Sep 2023 AA Total exemption full accounts made up to 30 June 2023
01 Jun 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
24 May 2023 SH01 Statement of capital following an allotment of shares on 19 May 2023
  • GBP 3,538.51
02 Mar 2023 AP01 Appointment of Dr Joanne Phoenix as a director on 22 July 2022
07 Nov 2022 AA Total exemption full accounts made up to 30 June 2022
04 Nov 2022 CS01 Confirmation statement made on 2 November 2022 with updates
18 Aug 2022 TM01 Termination of appointment of Owen Stephen Alexander Sennitt as a director on 26 July 2022